| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/29/2014 | CN103536565A Cefuroxime sodium composition freeze-dried powder for injection |
| 01/29/2014 | CN103536564A Cefonicid sodium composition powder for injection |
| 01/29/2014 | CN103536563A Levorotatory-pantoprazole sodium composition freeze-dried powder for injection |
| 01/29/2014 | CN103536562A Ambroxol hydrochloride composition freeze-dried powder for injection |
| 01/29/2014 | CN103536561A Sulbactam sodium composition freeze-dried powder for injection |
| 01/29/2014 | CN103536560A Ceftezole sodium composition powder for injection |
| 01/29/2014 | CN103536559A Biapenem composition freeze-dried powder for injection |
| 01/29/2014 | CN103536558A Cefoperazone sodium composition freeze-dried powder for injection |
| 01/29/2014 | CN103536557A Doxofylline composition freeze-dried powder for injection |
| 01/29/2014 | CN103536556A Pefloxacin mesylate composition freeze-dried powder for injection |
| 01/29/2014 | CN103536555A Ceftriaxone sodium composition freeze-dried powder for injection |
| 01/29/2014 | CN103536554A Ribostamycin sulfate composition freeze-dried powder for injection |
| 01/29/2014 | CN103536553A Immune ribonucleic acid composition freeze-dried powder injection |
| 01/29/2014 | CN103536552A Cisatracurium besilate composition freeze-dried powder for injection |
| 01/29/2014 | CN103536551A Fluorouracil composition freeze-dried powder for injection |
| 01/29/2014 | CN103536550A Flomoxef sodium composition freeze-dried powder for injection |
| 01/29/2014 | CN103536549A Erlotinib composition freeze-dried powder for injection |
| 01/29/2014 | CN103536548A Oryzanol freeze-dried powder composition for injection, and preparation method thereof |
| 01/29/2014 | CN103536547A Roxithromycin composition freeze-dried powder for injection |
| 01/29/2014 | CN103536546A Cyclophosphamide composition freeze-dried powder for injection |
| 01/29/2014 | CN103536545A Daunorubicin composition freeze-dried powder for injection |
| 01/29/2014 | CN103536544A Capecitabine composition freeze-dried powder for injection |
| 01/29/2014 | CN103536543A Oxiracetam composition freeze-dried powder for injection |
| 01/29/2014 | CN103536542A Injection-use ciprofloxacin composition lyophilized powder injection |
| 01/29/2014 | CN103536541A Clarithromycin freeze-dried injection and preparation method thereof |
| 01/29/2014 | CN103536540A Rifampin lyophilized powder and preparation method thereof |
| 01/29/2014 | CN103536539A Dextromethorphan hydrobromide lyophilized powder and preparation method thereof |
| 01/29/2014 | CN103536538A Expansive pellet for effectively masking taste and preparation method thereof |
| 01/29/2014 | CN103536537A Preparation method of lung targeted therapeutic medicine gefitinib PLGA [poly(lactic-co-glycolic acid) microspheres |
| 01/29/2014 | CN103536536A Wettability solid dispersing powder of florfenicol composition and preparation method thereof |
| 01/29/2014 | CN103536535A Dabigatran etexilate liposome |
| 01/29/2014 | CN103536531A Preparation method of long-acting injection containing danofloxacin mesylate |
| 01/29/2014 | CN103536530A Doxycycline hydrochloride long-acting injection and preparation method |
| 01/29/2014 | CN103536529A Ceftiofur-containing long-acting injection and preparation method |
| 01/29/2014 | CN103536528A Riboflavin sodium phosphate injection and preparation process thereof |
| 01/29/2014 | CN103536527A Dextromethorphan hydrobromide injection and preparation method thereof |
| 01/29/2014 | CN103536526A 帕罗西汀注射液及其制备方法 Paroxetine injection and its preparation method |
| 01/29/2014 | CN103536525A Preparation method of intraocular controlled release agent of interleukin 18 |
| 01/29/2014 | CN102949352B Decitabine freeze-dried powder injection and preparation method thereof |
| 01/29/2014 | CN102895665B Preparation method of targeting graphene nano-grade drug carrier |
| 01/29/2014 | CN102772417B Period effect percutaneous patch of self viscosity elastic body substrate containing testosterone and preparation method thereof |
| 01/29/2014 | CN102764267B Carbomer cervical gel |
| 01/29/2014 | CN102727891B Modified photosensitizer based on 5-aminolaevulic acid and preparation method thereof |
| 01/29/2014 | CN102657847B Application of toad maggot protein in medicine used for treating rectal cancer |
| 01/29/2014 | CN102600091B Itopride hydrochloride dispersible tablet composition |
| 01/29/2014 | CN102552920B Entecavir-containing medicinal composition and preparation method thereof |
| 01/29/2014 | CN102552173B Carotenoid oil suspension with high bioavailability and preparation method thereof |
| 01/29/2014 | CN102475687B Decitabine freeze-dry powder injection solution |
| 01/29/2014 | CN102351967B High-molecular material containing cholic acid and liver-targeting drug delivery nanoparticle modified by same |
| 01/29/2014 | CN102036653B Injectable sustained-release pharmaceutical formulation and the preparation method thereof |
| 01/29/2014 | CN101947199B Nifedipine mucilage and preparation method thereof |
| 01/29/2014 | CN101919805B Freeze-dried molded products containing magnesium ascorbyl phosphate |
| 01/29/2014 | CN101912600B Method for improving stability of insulin in solution |
| 01/29/2014 | CN101842109B Peptides derivatized with A-B-C-D- and their therapeutical use |
| 01/29/2014 | CN101821369B Process for producing highly purified orange roughy oil |
| 01/28/2014 | US8637659 Mono-and disaccharide derivatives |
| 01/28/2014 | US8637579 Process to thicken aqueous compositions by means of organophosphate polymers |
| 01/28/2014 | US8637468 Synthetic cholesterylamine-linker derivatives for agent delivery into cells |
| 01/28/2014 | US8637466 Multi-arm polymeric alkanoate conjugates |
| 01/28/2014 | US8637451 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/28/2014 | US8637083 Stable formulations for lyophilizing therapeutic particles |
| 01/28/2014 | US8637077 Sustained-release preparation |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | US8636993 Water-in-oil emulsions with anionic groups, compositions, and methods |
| 01/28/2014 | US8636992 Thickener compositions comprising sclerotium gum and a copolymer |
| 01/28/2014 | CA2731766C Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 01/28/2014 | CA2723458C Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 01/28/2014 | CA2721927C Auris formulations for treating otic diseases and conditions |
| 01/28/2014 | CA2671461C Vesicles of self-assembling block copolymers and methods for making and using the same |
| 01/28/2014 | CA2654522C Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as exipient |
| 01/28/2014 | CA2652280C Polymers for functional particles |
| 01/28/2014 | CA2625856C Drug delivery systems |
| 01/28/2014 | CA2616877C Systems and methods for manufacturing liposomes |
| 01/28/2014 | CA2599734C Humanized l243 antibodies |
| 01/28/2014 | CA2592030C Solid dosage form comprising proton pump inhibitor and suspension made thereof |
| 01/28/2014 | CA2565347C Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies |
| 01/28/2014 | CA2534360C Methods for expression and purification of immunotoxins |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/28/2014 | CA2484318C Warming and nonirritating lubricant antifungal gel compositions |
| 01/23/2014 | WO2014015334A1 System and methods for nanostructure protected delivery of treatment agent and selective release thereof |
| 01/23/2014 | WO2014015024A2 Non-surgical method of treatment for cataract |
| 01/23/2014 | WO2014014890A1 Targeted therapeutic nanoparticles |
| 01/23/2014 | WO2014014753A1 Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity |
| 01/23/2014 | WO2014014645A1 Systems and methods for oral administration of a therapy |
| 01/23/2014 | WO2014014436A1 Improved application of liquids to solid particles |
| 01/23/2014 | WO2014014434A1 Preparation for the treatment of tuberculosis |
| 01/23/2014 | WO2014014384A1 Drug having an antiviral, anti-inflammatory, immuno-modulating and analgesic effect |
| 01/23/2014 | WO2014014364A1 Injectable antibiotic formulations and their methods of use |
| 01/23/2014 | WO2014014363A1 Injectable antibiotic formulations and their methods of use |
| 01/23/2014 | WO2014014150A1 Pharmaceutical composition comprising antiviral neuraminidase inhibitor and permeation enhancer for enhanced oral bioavailability |
| 01/23/2014 | WO2014014010A1 Tablet having dry-ink film on surface thereof, and ink for inkjet printer |
| 01/23/2014 | WO2014013903A1 Liquid composition containing taxane-based active ingredient, process for producing same, and liquid medicinal preparation |
| 01/23/2014 | WO2014013473A1 Nanoconstructs with pharmacological activity |
| 01/23/2014 | WO2014013423A1 Glucosaline maintenance solution for pediatric parenteral administration |
| 01/23/2014 | WO2014013195A1 Use of an amphoteric chelating agent for preventing contact allergies |
| 01/23/2014 | WO2014013194A1 Use of a cream that protects against the effects of aggressive chemical agents in contact with the skin |
| 01/23/2014 | WO2014013027A1 Medicament for wound treatment |
| 01/23/2014 | WO2014012571A1 Complex of agomelatine and cyclodextrin |
| 01/23/2014 | WO2014012479A1 Compounds for targeted immunotherapy |
| 01/23/2014 | WO2014012399A1 Recombinational lucid ganoderma immunomodulatory protein methoxypolyethyleneglycol propionic acid succinimidyl ester modifier, preparation method and use |